This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Umed Singh: Innovator in Anticancer Research
Introduction
Umed Singh is a notable inventor based in Jammu, India. He has made significant contributions to the field of cancer research through his innovative work on phosphoinositide 3-kinase (PI3K) inhibitors. His research focuses on developing new therapeutic agents that can combat cancer effectively.
Latest Patents
Umed Singh holds a patent for "1,3,5-triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof." This invention describes heterocyclic compounds of general Formula 1, which inhibit PI3K and can be utilized as anticancer agents. The method of preparation for these compounds is also detailed in the patent, showcasing his commitment to advancing cancer treatment.
Career Highlights
Umed Singh is affiliated with the Council of Scientific & Industrial Research, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on cancer therapies, making him a valuable asset in the scientific community.
Collaborations
Umed Singh collaborates with talented individuals such as Thanusha Thatikonda and Suresh Kumar. Their combined expertise enhances the research efforts and contributes to the development of innovative solutions in cancer treatment.
Conclusion
Umed Singh's contributions to the field of anticancer research through his patented inventions highlight his dedication to improving healthcare outcomes. His work exemplifies the importance of innovation in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile